Cloned Genome of Infectious Hepatitis C Virus of Genotype 2a and Uses Thereof

The current invention provides a nucleic acid sequence comprising the genome of infectious hepatitis C viruses (HCV) of genotype 2a. The encoded polyprotein differs from those of the infectious clones of genotypes 1a and 1b (U.S. Patent 6,153,421) by approximately thirty (30) percent. It covers the use of this sequence and polypeptides encoded by all or part of the sequence, in the development of vaccines and diagnostic assays for HCV and the development of screening assays for the identification of antiviral agents for HCV. Additional information can be found in Yanagi et al. (1999), Virology 262, 250-263.IC: NIAIDNIH Ref. No.: E-100-1999-0TAB No: TAB-488Provider Technology ID: 488Updated On: Jul 6, 2020Date Published: Monday, July 6, 2020Patent Application: 09/980,55911/451,212PCT/US00/1544660/137,693Patent Authority: USEIRUSPCTUSPatent Number: 7,084,266Lead Inventor: Inventor IC: NIAIDNIAIDNIAIDNIAIDLPM FIrst Name: PeterLPM Last Name: SoukasLPM Address: 5601 Fishers Lane, Suite 6D (MSC 9804)LPM City: RockvilleInv Is lead: LPM Zip: 20892-9804LPM State: MDLPM Phone: [phone]LPM Email: [e-mail] Suffix: J.D.LPM Organization: NIH Office of Technology TransferLPM Fax: [phone]DTDT Classification: Infectious DiseasesVaccinesViralResearch MaterialsDTDT Description: Infectious DiseasesInfectious Diseases - VaccinesInfectious Diseases - ...

Source: NIH OTT Licensing Opportunities - July 6, 2020 Category: Research Authors: ott-admin Source Type: research